4//SEC Filing
Salvagno Ralph T 4
Accession 0001493152-18-002844
CIK 0001354591other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 3:00 PM ET
Size
8.6 KB
Accession
0001493152-18-002844
Insider Transaction Report
Form 4
Salvagno Ralph T
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2017-08-17$0.06/sh+5,000,000$300,000→ 17,450,000 total(indirect: By LLC) - Other
Common Stock
2017-08-17−1,250,000→ 12,450,000 total(indirect: By LLC) - Other
Series A Preferred Stock
2017-08-17+1,250,000→ 1,250,000 total(indirect: By LLC)
Footnotes (2)
- [F1]Conversion of common stock into Series A preferred stock on a 1:1 basis.
- [F2]Accrued compensation converted into common stock at a conversion rate of $0.06/share.
Documents
Issuer
PetLife Pharmaceuticals, Inc.
CIK 0001354591
Entity typeother
Related Parties
1- filerCIK 0001677900
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 3:00 PM ET
- Size
- 8.6 KB